Breadcrumb Home Yale Technologies Sulabha Biopharmaceuticals Yale Innovation Summit - Day 1 05/18/2021 Sulabha Biopharmaceuticals Download Pitch Presentation Ashtekar, Kumar.pdf (31.3 MB) Investigators Mark A. Lemmon, Ph.D., FRS David A. Sackler Professor of Pharmacology; Associate Cancer Center Director for Basic Science, Yale Cancer Center; Co-director, Cancer Biology Institute Kumar Ashtekar Associate Research Scientist in Pharmacology
Mark A. Lemmon, Ph.D., FRS David A. Sackler Professor of Pharmacology; Associate Cancer Center Director for Basic Science, Yale Cancer Center; Co-director, Cancer Biology Institute
